Faricimab, CAS 1607793-29-2

Description: Faricimab, a bispecific antibody, simultaneously targets angiopoietin-2 and vascular endothelial growth factor-A (VEGF-A), and is utilized in research on diabetic macular edema (DME) [1].

CAS Number: 1607793-29-2

• Artikelnummer: TGMT78253-5mg
• Hersteller: TargetMol Chemicals
• Hersteller Artikelnummer: T78253-5mg
• Green Labware: Nein
• Verpackungseinheit: 5 mg
• Mengeneinheit: STK